$ANIK Recent Headlines
Post# of 88914
Dow edges to less-charted technical territory
11:48 a.m. May 1, 2014
- Michael Ashbaugh
Dow edges to less-charted territory
11:27 a.m. May 1, 2014
- Michael Ashbaugh
S&P 500 extends the break to ‘clear skies’ territory
11:46 a.m. March 6, 2014
- Michael Ashbaugh
Stock futures edge higher ahead of home sales
9:11 a.m. Feb. 26, 2014
- William L. Watts
First Solar shares burned as earnings disappoint
7:05 p.m. Feb. 25, 2014
- Wallace Witkowski
Amgen boosts biotech sector to close up
6:23 p.m. March 11, 2011
- Wallace Witkowski
Human Genome rallies against biotech downturn
6:04 p.m. March 10, 2011
- Wallace Witkowski
Illumina dives, Anika rallies on earnings reports
11:53 a.m. Oct. 28, 2009
- Val Brickates Kennedy
Genzyme, Merck lead as drug stocks move higher
1:04 p.m. Aug. 21, 2009
- Val Brickates Kennedy
Thursday's biggest gaining and declining stocks
5:07 p.m. Aug. 20, 2009
- MarketWatch
Drug stocks gain; Anika zooms on drug approval
12:32 p.m. Aug. 20, 2009
- Val Brickates Kennedy
Wednesday's biggest stock gainers and decliners
5:27 p.m. July 25, 2007
- Gabriel Madway
Stocks in focus for Wednesday
7:37 p.m. July 24, 2007
- MarketWatch
Friday's biggest stock gainers and decliners
4:42 p.m. April 13, 2007
- Michael Baron
Stocks in focus Friday
7:14 p.m. April 12, 2007
- Katherine Hunt
Anika Therapeutics receives CE Mark approval for Elevess
5:30 p.m. April 12, 2007
- Katherine Hunt
Anika Therapeutics up 5.3% at $14.10
10:46 a.m. Dec. 21, 2006
- Tomi Kilgore
Anika Thera gets FDA approval for cosmetic tissue augment
9:52 a.m. Dec. 21, 2006
- Thomas Middleton
Tuesday's biggest stock gainers and decliners
6:29 p.m. Nov. 28, 2006
- Gabriel Madway
Anika receives FDA approvable letter for tissue product
1:41 p.m. Nov. 28, 2006
- Katherine Hunt
10-Q: ANIKA THERAPEUTICS, INC.
5:30 p.m. May 5, 2014
- Edgar Online - (EDG = 10Q, 10K)
Insider Trading Alert - ANIK, TRLA And AMED Traded By Insiders
10:15 a.m. May 5, 2014
- TheStreet.com
Anika Therapeutics' CEO Discusses Q1 2014 Results - Earnings Call Transcript
4:04 p.m. April 30, 2014
- Seeking Alpha
Notable earnings after Tuesday’s close
5:35 p.m. April 28, 2014
- Seeking Alpha
Some IBD 50 Stocks May Be Forming Bases
5:42 p.m. April 25, 2014
- Investors Business Daily
Facebook, Arris, Grifols Initiate New Bases
5:35 p.m. April 11, 2014
- Investors Business Daily
Biotech IPOs Adamas, Cerulean Slump In Trading Debut
3:02 p.m. April 10, 2014
- Investors Business Daily
PolyOne, Anika, Methode Among The Leading Small Caps
7:02 a.m. April 10, 2014
- Investors Business Daily
Biotechs, Medicals Get Hurt Amid Price-Inquiry News
5:26 p.m. March 21, 2014
- Investors Business Daily
10-K: ANIKA THERAPEUTICS INC
5:29 p.m. March 13, 2014
- Edgar Online - (EDG = 10Q, 10K)
Mutual Funds Loading Up On These 3 Top-Rated Stocks
7:02 a.m. March 7, 2014
- Investors Business Daily
Insider Trading Alert - SWK, ANIK And NYT Traded By Insiders
10:15 a.m. March 4, 2014
- TheStreet.com
Anika Therapeutics (ANIK) Showing Signs Of A Dead Cat Bounce Today
9:55 a.m. March 3, 2014
- TheStreet.com
Cramer's Mad Money - 10 Biggest Gains (2/27/14)
6:22 a.m. Feb. 28, 2014
- Seeking Alpha
Anika Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript
1:43 p.m. Feb. 27, 2014
- Seeking Alpha
Anika Therapeutics (ANIK) In A Perilous Reversal
9:46 a.m. Feb. 27, 2014
- TheStreet.com
Mid-Day Market Update: First Solar Falls On Downbeat Results; Anika Therapeutics Shares Jump
11:52 a.m. Feb. 26, 2014
- benzinga.com
Anika Arthritis Drug Approval Sends Stock Soaring
10:47 a.m. Feb. 26, 2014
- Investors Business Daily
Today Anika Therapeutics (ANIK) Hits New Lifetime High
9:46 a.m. Feb. 26, 2014
- TheStreet.com
Benzinga's Volume Movers
9:37 a.m. Feb. 26, 2014
- benzinga.com
Anika Therapeutics Reports First Quarter 2014 Financial Results
4:08 p.m. April 29, 2014
- BusinessWire - BZX
Anika Therapeutics Announces Date of First-Quarter 2014 Financial
Results Conference Call
5:09 p.m. April 16, 2014
- BusinessWire - BZX
Anika Therapeutics Announces First U.S. Commercial Sale of Monovisc®
2:31 p.m. April 15, 2014
- BusinessWire - BZX
Anika Therapeutics Announces Dismissal of MONOVISC®
U.S. Patent Infringement Lawsuit
8:55 a.m. March 13, 2014
- BusinessWire - BZX
Anika Therapeutics to Present at Canaccord Genuity Musculoskeletal
Conference March 11
5:06 p.m. March 4, 2014
- BusinessWire - BZX
Translational Regenerative Medicine: Market Prospects 2014-2024
12:35 p.m. Feb. 27, 2014
- PR Newswire - PRF
Chesapeake Energy Falls after Missing Estimates; Anika Therapeutics Gets FDA Approval for Monovisc
2:16 a.m. Feb. 27, 2014
- ACCESSWIRE
Anika Therapeutics Reports Fourth Quarter and Full Year 2013
Financial Results
5:06 p.m. Feb. 26, 2014
- BusinessWire - BZX
FDA Approves MONOVISC®, A New Single
Injection Treatment for Treatment of Pain Due to Osteoarthritis of the
Knee
5:00 p.m. Feb. 25, 2014
- BusinessWire - BZX
Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2013
Financial Results Conference Call
5:06 p.m. Feb. 12, 2014
- BusinessWire - BZX
Translational Regenerative Medicine: Market Prospects 2014-2024
11:11 a.m. Feb. 12, 2014
- PR Newswire - PRF
Anika Therapeutics to Present at the Tenth Annual Noble Financial Equity Conference on January 20
5:40 p.m. Jan. 9, 2014
- BusinessWire
Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics
9:00 a.m. Dec. 24, 2013
- PR Newswire
Biotech Firms Participate in Upcoming Conferences; Sees Steady Numbers around Thanksgiving - Research Report on BioMarin, Halozyme, PDL BioPharma, Anika Therapeutics, and Exelis
9:00 a.m. Dec. 3, 2013
- PR Newswire
FDA Approvals, Public Offerings and Stock Price Movements - Research Report on BioMarin, AEterna Zentaris, Charles River, Anika Therapeutics and Halozyme Therapeutics
9:00 a.m. Nov. 25, 2013
- PR Newswire
Allegion plc Set to Join the S&P 500; J.C. Penney to Join S&P MidCap 400; Aeropostle, Anika Therapeutics to Join S&P SmallCap 600
6:47 p.m. Nov. 22, 2013
- PR Newswire
Presentations, Executive Appointments, and Quarterly Financial Reports - Research Report on Jazz Pharmaceuticals, Insulet, The Cooper Companies, Anika Therapeutics, and Sangamo Biosciences
9:00 a.m. Nov. 6, 2013
- PR Newswire
Anika Therapeutics Reports 20% Total Revenue Growth and Record Third-Quarter Earnings
4:05 p.m. Oct. 30, 2013
- BusinessWire
Anika Therapeutics Announces Date of Third-Quarter 2013 Financial Results Conference Call
8:30 a.m. Oct. 15, 2013
- BusinessWire
Anika Therapeutics Appoints Industry-Recognized R&D Executive John W. Sheets, Jr., Ph.D. as Chief Scientific Officer
3:10 p.m. Oct. 2, 2013
- BusinessWire